期刊文献+

卢帕他定——新型的组胺H1受体和血小板活化因子受体双重拮抗剂 被引量:7

下载PDF
导出
摘要 卢帕他定是一种具有组胺H1受体和血小板活化因子受体双重拮抗作用的新型抗过敏药,能够作用于过敏反应发生的不同环节进而抑制炎症反应。药效学研究表明卢帕他定具有与二代抗组胺药相似或更强的抗组胺活性。该药对中枢神经系统影响较小,安全剂量范围较广。临床研究表明,卢帕他定低剂量口服能有效地控制季节性和常年过敏性鼻炎的症状。卢帕他定对部分过敏性皮肤疾病的临床研究也在进行之中。
作者 卜今 陈志强
机构地区 中国医学科学院
出处 《中国中西医结合皮肤性病学杂志》 CAS 2006年第3期182-184,共3页 Chinese Journal of Dermatovenereology of Integrated Traditional and Western Medicine
  • 相关文献

参考文献15

  • 1[1]Christie PE,Henderson WR Jr.Lipid inflannatory mediators:leukotrienes,prostaglandins,platelet-activating factor[J].Clin Allergy Immunol,2002,16:233-254. 被引量:1
  • 2[2]Ricardo Caballero,Carmen Valenzuela,MoAnica Longobardo,et al.Effects of rupatadine,a new dual antagonist of histamine and platelet-activating factor receptors,on human cardiac Kv1.5channels[J].British Journal of Pharmacology,1999 128(5):1071-1081. 被引量:1
  • 3[3]Barbanoj Mj,Garcia-Gea C,Morte A,et al.Central and peripheral evaluation of rnpatadine,a new antihistamine/platelet-activating factor antagonist,at different doses in healthy volunteers[J].Neuropsychobiology,2004,50(4):311-321. 被引量:1
  • 4[4]Manuel Merlos,Marta Giral,Dolors Balsa,et al.Rupatadine,a new potent,orally active dual antagonist of histamine and platelet activating factor(PAF)[J].J Pharmacol Exp Ther,1997,280(1):114-121. 被引量:1
  • 5[5]Inaki Izquierdo,Manuel Merlos,Julian Garcfa-Rafanell,et al.Rupatadine:a new selective histamine H1 receptor and platelet-activating factor(PAF)antagonist[J].Drugs Today(Barc),2003,39(6):451-468. 被引量:1
  • 6[6]Mireia Queralt,Pilar Brazís,Manuel Merlos,et al.Inhibitory effects of rupatadine on mast cell histamine release and skin wheal development induced by ascaris suum in hypersensitive dogs[J].Drug Development Research,1998,44:49-55. 被引量:1
  • 7[7]Merlos M,Giral M,Balsa D,et al.Rupatadine inhibits the eosinophil recruitment in BAL fluid of ovalbumin-sensitized guinea pigs[J].J Allergy Clin Immunol,1998,101(1 part 2):S218. 被引量:1
  • 8[8]Queralt M,Brazís P,Merlos M,et al.In vitro inhibitory effect of rupatadine on histamine and TNF-c release from dispersed canine skin mast cells and the human mast cell line HMC-1[J].Inflammres,2000,49(7):355-360. 被引量:1
  • 9[9]Izquierdo I,Nieto C.Pharmacokinetic and dose linearity of rupatadine fumarate in healthy volunteers[J].Meth Find Exp Clin Pharmaxol,1997,19(Suppl A):189. 被引量:1
  • 10[10]Saint-Martin F,Dumur JP,Pérez I,et al.A randomized,doubleblind,parallel-group study,comparing the efficacy and safety of rupatadine(20 and 10 mg),a new PAF and H1 receptor-specific histamine antagonist,to loratadine 10mg in the treatment of seasonal allergic rhinitis[J].J Invest Allergol Clin Immunol,2004,14(1):34-40. 被引量:1

同被引文献31

  • 1王震宇,朱雄,王尔华.卢帕他定中间体5-甲基吡啶-3-羧酸的合成工艺改进[J].药学进展,2005,29(1):31-33. 被引量:3
  • 2周海钧.药品注册的国际技术要求(质量部分)[M].北京:人民卫生出版社,2000:87. 被引量:6
  • 3国家药典委员会.中华人民共和国药典(二部)[S].2005年版.北京:化学工业出版社,2005:附录83-90. 被引量:4
  • 4John G, Dan S, David D,etal. Degradation product of loratadine[J].Journal of Pharmaceutical and Biomedical Analysis , 2007, 43: 1191-1192. 被引量:1
  • 5Carceller E, Recasens N, etal. 8 - chloro- 11 - [ 1 - [ (5 - met hyl - 3 - pyridyl ) -methyl ] - 4 - piperidyliden] 6, 11 - dihydro - 5H - benzo [5,6]cyclohepta [1,2- b]pyridine [P]. US5407941,1995-9-18. 被引量:1
  • 6Carceller E, Merlos N, et al. [(3- pridylalakyl) piperidy lidene] benzocyclo heptapyridine Derivatives as Dual Antagonists of PAF and Histamine [J]. J Med Chem,1994,37(17) :2697-2703. 被引量:1
  • 7Martinez-C6cera C, De Molina M, Marti-Guadaho E, et al. Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind parallel study [ J]. J Investig Allergol Clin Immunol, 2005, 15 ( 1 ) : 22-29. 被引量:1
  • 8Guadaho EM, Serra-Batlles J, Meseguer J, et al. Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study [J]. Allergy-, 2004, 59(1): 766-771. 被引量:1
  • 9Keam S J, Plosker GL. Rupatadine: a review of its use in the management of allergic disorders [ J]. Drugs, 2007, 67 (3) : 457- 474. 被引量:1
  • 10Solans A, Carb6 ML, Pefia J, et al. Influence of Food on the Oral Bioavailability of Rupatadine Tablets in Healthy Volunteers: A Single-Dose, Randomized, Open-Label, Two-Way Crossover Study [J]. Clinical Therapeutics, 2007, 29 (5): 900-908. 被引量:1

引证文献7

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部